ASX:M7TMach7 Technologies Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Mach7 Technologies Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add A$0.57 -0.01 (-1.71 %) (As of 05/13/2020) Add Compare Share Today's RangeA$0.54Now: A$0.58▼A$0.5850-Day RangeA$0.47MA: A$0.56▼A$0.6252-Week RangeA$0.33Now: A$0.58▼A$0.95Volume272,627 shsAverage VolumeN/AMarket Capitalization$105.13 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAdvanced ChartCompetitorsInsider TradesHeadlines Mach7 Technologies Limited provides enterprise imaging data sharing, storage, and interoperability solutions for healthcare enterprises worldwide. It offers Management Studio that enables healthcare delivery organizations to own, archive, and communicate imaging data from across the enterprise and connect that data with the electronic medical record. The company's Management Studio comprises enterprise imaging platform, vendor neutral archive, communication workflow engine, routing engine, fetching engine, and migration engine products. It also provides Diagnostic Studio that drives specialty workflows. The company's Diagnostic Studio solutions include PACS solution, Universal Worklist, and QC module. In addition, the company offers Clinical Studio, which provides access to view, navigate, review, and share patient medical data over the Web and across the enterprise. Its Clinical Studio solutions consist of clinical portal, clinical viewer, image sharing, and procedure import/export products. Further, the company provides customer training, software installation, and maintenance and support services; and archive migration services. Mach7 Technologies Limited was founded in 2007 and is based in South Burlington, Vermont.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Mach7 Technologies. Previous Next 2.8 Community Rank Outperform VotesMach7 Technologies has received 14 “outperform” votes. (Add your “outperform” vote.)Underperform VotesMach7 Technologies has received 11 “underperform” votes. (Add your “underperform” vote.)Community SentimentMach7 Technologies has received 56.00% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Mach7 Technologies and other stocks. Vote “Outperform” if you believe M7T will outperform the S&P 500 over the long term. Vote “Underperform” if you believe M7T will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldMach7 Technologies does not currently pay a dividend.Dividend GrowthMach7 Technologies does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Mach7 Technologies insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Mach7 Technologies is -44.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Mach7 Technologies is -44.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioMach7 Technologies has a P/B Ratio of 3.14. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 0.0Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.56 out of 5 stars Industry, Sector and Symbol Stock Exchange ASX Industry Health Information Services Sub-IndustryN/A SectorComputer and Technology Current SymbolASX:M7T Previous Symbol CUSIPN/A CIKN/A Webwww.mach7t.com Phone802-861-7745Debt Debt-to-Equity Ratio1.22 Current Ratio4.94 Quick Ratio4.87Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$14.91 million Price / Sales7.05 Cash FlowA$0.14 per share Price / Cash Flow4.17 Book ValueA$0.18 per share Price / Book3.14Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding Shares182,828,992Market Cap$105.13 million Next Earnings DateN/A OptionableNot Optionable Receive M7T News and Ratings via Email Sign-up to receive the latest news and ratings for M7T and its competitors with MarketBeat's FREE daily newsletter. Mach7 Technologies (ASX:M7T) Frequently Asked Questions How has Mach7 Technologies' stock been impacted by COVID-19 (Coronavirus)? Mach7 Technologies' stock was trading at A$0.62 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, M7T stock has decreased by 7.3% and is now trading at A$0.58. View which stocks have been most impacted by Coronavirus. Has Mach7 Technologies been receiving favorable news coverage? News headlines about M7T stock have been trending extremely negative on Friday, according to InfoTrie Sentiment Analysis. The research firm identifies positive and negative media coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Mach7 Technologies earned a news sentiment score of -4.8 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View the latest news aboutMach7 Technologies. Who are some of Mach7 Technologies' key competitors? Some companies that are related to Mach7 Technologies include Alcidion Group (ALC), Kneat.com (KSI), Medadvisor (MDR), Resapp Health (RAP), CogState (CGS), Sensyne Health (SENS), Reliq Health Technologies (RHT), Novita Healthcare (NHL), Vitalhub (VHI), Induction Healthcare Group (INHC), Oneview Healthcare (ONE), 1ST Group (1ST), Diagnos (ADK), Emerald Clinics (EMD) and ICSGlobal (ICS). View all competitors. Who are Mach7 Technologies' key executives? Mach7 Technologies' management team includes the following people: Mr. Mike Lampron, COO & Interim CEOMr. Ravi Krishnan, Founder & Chief Strategy OfficerMs. Jennifer Pilcher, Global CFO & Corp. Sec. What is Mach7 Technologies' stock symbol? Mach7 Technologies trades on the ASX under the ticker symbol "M7T." What is Mach7 Technologies' stock price today? One share of M7T stock can currently be purchased for approximately A$0.58. How big of a company is Mach7 Technologies? Mach7 Technologies has a market capitalization of $105.13 million and generates $14.91 million in revenue each year. What is Mach7 Technologies' official website? The official website for Mach7 Technologies is www.mach7t.com. How can I contact Mach7 Technologies? The company can be reached via phone at 802-861-7745. This page was last updated on 5/29/2020 by MarketBeat.com Staff
